These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29902957)

  • 1. Is Muscle MELD a More Promising Predictor for Mortality After Living Donor Liver Transplantation?
    Badawy A; Kaido T; Hamaguchi Y; Anazawa T; Yagi S; Fukumitsu K; Kamo N; Okajima H; Uemoto S
    Prog Transplant; 2018 Sep; 28(3):213-219. PubMed ID: 29902957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Different Scoring Systems Based on Both Donor and Recipient Characteristics for Predicting Outcome after Living Donor Liver Transplantation.
    Ma Y; Wang Q; Yang J; Yan L
    PLoS One; 2015; 10(9):e0136604. PubMed ID: 26378786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which score system can best predict recipient outcomes after living donor liver transplantation?
    Chung IS; Park M; Ko JS; Gwak MS; Kim GS; Lee SK
    Transplant Proc; 2012 Mar; 44(2):393-5. PubMed ID: 22410025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different Score Systems to Predict Mortality in Living Donor Liver Transplantation: Which Is the Winner? The Experience of an Egyptian Center for Living Donor Liver Transplantation.
    El Amir M; Gamal Eldeen H; Mogawer S; Esmat G; El-Shazly M; El-Garem N; Abdelaziz MS; Salah A; Hosny A
    Transplant Proc; 2015 Dec; 47(10):2897-901. PubMed ID: 26707310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
    Ikegami T; Imai D; Wang H; Yoshizumi T; Yamashita Y; Ninomiya M; Iguchi T; Bekki Y; Shirabe K; Maehara Y
    Transplantation; 2014 Feb; 97(4):457-62. PubMed ID: 24531822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (D+10) MELD as a novel predictor of patient and graft survival after adult to adult living donor liver transplantation.
    Soin AS; Goja S; Yadav SK; Tamang TY; Rastogi A; Bhangui P; Thiagrajan S; Raut V; Babu RY; Saigal S; Saraf N; Choudhary NS; Vohara V
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28239914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposal of Muscle-MELD Score, Including Muscularity, for Prediction of Mortality After Living Donor Liver Transplantation.
    Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Shirai H; Yagi S; Hammad A; Okajima H; Uemoto S
    Transplantation; 2016 Nov; 100(11):2416-2423. PubMed ID: 27495765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of postoperative Model for End-Stage Liver Disease scoring system for evaluating liver graft function after living donor liver transplantation.
    Toshima T; Ikegami T; Kimura K; Harimoto N; Yamashita Y; Yoshizumi T; Soejima Y; Ikeda T; Shirabe K; Maehara Y
    Transplant Proc; 2014; 46(1):81-6. PubMed ID: 24507030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal for a New Predictive Model of Short-Term Mortality After Living Donor Liver Transplantation due to Acute Liver Failure.
    Chung HS; Lee YJ; Jo YS
    Ann Transplant; 2017 Feb; 22():101-107. PubMed ID: 28220036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
    Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
    Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
    Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-MELD, the Product of Donor Age and Preoperative MELD, Predicts Surgical Outcomes After Living Donor Liver Transplantation, Especially in the Recipients With HCV-positive and Smaller Grafts.
    Tanemura A; Mizuno S; Kato H; Murata Y; Kuriyama N; Azumi Y; Kishiwada M; Usui M; Sakurai H; Isaji S
    Transplant Proc; 2016 May; 48(4):1025-31. PubMed ID: 27320548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after live donor versus deceased donor liver transplantation: propensity score-matched study.
    Kaltenmeier C; Liu H; Zhang X; Ganoza A; Crane A; Powers C; Gunabushanam V; Behari J; Molinari M
    BJS Open; 2024 May; 8(3):. PubMed ID: 38837956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome.
    Khandoga A; Iskandarov E; Angele M; Gerbes A; Frey L; Ağayev B; Jauch KW; Werner J; Guba M
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):153-8. PubMed ID: 26545081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplant mortality risk assessment for adult-to-adult right-lobe living donor liver recipients with benign end-stage liver disease.
    Zhang M; Yin F; Chen B; Li Y; Yan L; Wen T; Li B
    Scand J Gastroenterol; 2012 Jul; 47(7):842-52. PubMed ID: 22546008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.
    Yadav SK; Saraf N; Saigal S; Choudhary NS; Goja S; Rastogi A; Bhangui P; Soin AS
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28497523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End-Stage Liver Disease and Hepatorenal Syndrome.
    Wong TC; Fung JY; Pang HH; Leung CK; Li HF; Sin SL; Ma KW; She BW; Dai JW; Chan AC; Cheung TT; Lo CM
    Hepatology; 2021 Jun; 73(6):2441-2454. PubMed ID: 33006772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Benefit of Living-Donor Liver Transplant.
    Jackson WE; Malamon JS; Kaplan B; Saben JL; Schold JD; Pomposelli JJ; Pomfret EA
    JAMA Surg; 2022 Oct; 157(10):926-932. PubMed ID: 35921119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of Proper Graft Selection in Adult Living-Donor Liver Transplant Recipients with Preoperative Deteriorated Condition.
    Iida T; Masuda K; Matsuyama T; Harada S; Nakamura T; Koshino K; Suzuki T; Nobori S; Ushogome H; Ito T; Sakamoto S; Uryuhara K; Okajima H; Kaihara S; Uemoto S; Yoshimura N
    Ann Transplant; 2017 Sep; 22():541-549. PubMed ID: 28883387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.